Fidelity MSCI Consumer Staples Index (FSTA)

The Organic & Non-GMO Market Is Now a Multi-Trillion-Dollar Force. Who's poisoning Americans food https://x.com/safehavenmoney/status/2062911880092320180

Enjoy the weekend! I’m off now. ☀️🛩️ … See you next week! 

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

Sitting at 025

The Organic & Non-GMO Market Is Now a Multi-Trillion-Dollar Force. Who's poisoning Americans food https://x.com/safehavenmoney/status/2062911880092320180

Looking at both sides, so if they just put all the R&D in the trash can - why did they buy Coretec?

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

Sitting at 025

A felon using dogs name to avoid SEC scrutiny is real class. Fooling nobody but the foolish.

Thanks
So that should settle the question !!
Just wondering why couldn’t the company IR respond to emails of posters from this board quickly and deny any relation to DcVax l , as the linked screenshot in your post seems quite definitive ?

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

Sitting at 025

???

Good grief are some of you delusional…. 

Specials has been in effect for a decade. Where’s the survival evidence other than a few fortunate outliers?

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

Sitting at 025

BNAI Out @24 IN @17.7 🚬📈 what a week! 

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

Sitting at 02

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

Sitting at 02

$IBIT WAS $72.00 IN OCTOBER 6TH 2025.LIKE 8 MONTHS AGO.NOW IT IS AT $34.45.SCARY.
6 Oct 2025
71.29
1.48
2.12%
71.01
71.82
70.71
68,543,175

"Plan B" 😆😆 How ironic. Hopefully we are all not looking for a TGLO morning after pill in a couple months. But hey, that's life in the big city!

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

Sitting at 025

PRSO, buy dips & HOLD VERY TIGHT! ;)

I think the increase in authorized share was to prevent a hostile takeover.

Bashmaster

An Early Feasibility Investigational Device Exemption (IDE) is a U.S. FDA regulatory pathway that allows medical device developers to conduct early, limited clinical testing (often first-in-human) on a new device before its design is fully finalized.

How Existing Clinical Data Benefi

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

Sitting at 025